ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 118 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $264,620 | -28.8% | 57,526 | 0.0% | 0.04% | +2.6% |
| Q2 2023 | $371,618 | -14.3% | 57,526 | 0.0% | 0.04% | -22.0% |
| Q1 2023 | $433,746 | -25.6% | 57,526 | 0.0% | 0.05% | -34.2% |
| Q4 2022 | $582,738 | +2.4% | 57,526 | 0.0% | 0.08% | +11.8% |
| Q3 2022 | $569,000 | -7.2% | 57,526 | 0.0% | 0.07% | +6.2% |
| Q2 2022 | $613,000 | +44.6% | 57,526 | +32.4% | 0.06% | +255.6% |
| Q1 2022 | $424,000 | -31.7% | 43,440 | 0.0% | 0.02% | -5.3% |
| Q4 2021 | $621,000 | -28.7% | 43,440 | 0.0% | 0.02% | -83.9% |
| Q3 2021 | $871,000 | – | 43,440 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |